Thursday, September 19, 2019

 


Aurinia Pharmaceuticals Inc
(TSX: AUP.TO) Add to Watchlist
$7.92
-0.55 (-6.49%)
as of Sep 18, 2019

Last 7.92
Change -0.55 (-6.49%)
Open 8.37
Prev. Close 8.47
Today's Range
7.85 8.43
52wk Range
6.61 10.47
Volume 78,941
Avg Volume 31,592

Recent Headlines
In recognition of Lupus Awareness Month and World Lupus Day, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH/TSX:AUP) (the "Company") a late clinical-stage biopharmaceutical company with ongoing research in lupus nephritis ("LN"), today recognized World Lupus Day and Lupus Awareness  (full story)
AUP.TO: 7.92 (-0.55), AUPH: 5.92 (-0.46)
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (the "Company") today announced that it will release its first quarter 2019 financial results on Tuesday, May 14, 2019, after the market closes. Aurinia's management team will host a conference call to discuss the company's  (full story)
AUP.TO: 7.92 (-0.55), AUPH: 5.92 (-0.46)
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) ("Aurinia" or the "Company"), a clinical stage biopharmaceutical company focused on the global immunology market, today announced it has appointed Dr. Daniel Billen to its Board of Directors. Dr. Billen's appointment is effect  (full story)
AUP.TO: 7.92 (-0.55), AUPH: 5.92 (-0.46)
--Dr. Richard M. Glickman to retire from executive and board roles and remain an advisor to the Company for one year  (full story)
AUP.TO: 7.92 (-0.55), AUPH: 5.92 (-0.46)
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) ("Aurinia" or the "Company") today reported its financial results for the fourth quarter and year ended December 31, 2018. Amounts, unless specified otherwise, are expressed in U.S. dollars.  (full story)
AUP.TO: 7.92 (-0.55), AUPH: 5.92 (-0.46)
Performance Comparison
Name Today 3-Month 1-Year
AUP.TO -6.49% -4.35% +7.61%
$TXCX -0.20% +2.05% +3.73%
$TXSC -0.11% +2.10% +4.75%
DJIA +0.13% +1.36% +3.43%
S&P 500 +0.03% +0.91% +3.53%

Key Statistics
Annual EPS -0.70
Dividend & Yield -- (--)
P/E Ratio N/A
Market Capitalization, $K 727,001
Weighted Alpha +2.60
Standard Deviation -1.97
Profit Margin -132.32%
Beta -0.12

Growth Rates
YTD -14.66%
1-Year +13.14%
3-Year +151.43%
5-Year +110.08%
© 2019 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.